Announcement of TTY Biopharm's unaudited income information in July 2020

Announcement of TTY Biopharm's unaudited income information in July 2020

2020.8.11

...

More

Announcement of TTY Biopharm's unaudited income information in June 2020

Announcement of TTY Biopharm's unaudited income information in June 2020

2020.7.10

...

More

Announcement of TTY Biopharm's unaudited income information in May 2020

Announcement of TTY Biopharm's unaudited income information in May 2020

2020.6.11

...

More

TTY Biopharm and PharmaMar entered into an exclusive agreement to commercialize Yondelis® in Taiwan, Hong Kong and Macao

TTY Biopharm and PharmaMar entered into an exclusive agreement to commercialize Yondelis® in Taiwan, Hong Kong and Macao

2020.6.9

...

More

Announcement of TTY Biopharm's unaudited income information in April 2020

Announcement of TTY Biopharm's unaudited income information in April 2020

2020.5.13

...

More

Announcement of TTY Biopharm's unaudited income information in March 2020

Announcement of TTY Biopharm's unaudited income information in March 2020

2020.4.14

...

More

Announcement of TTY Biopharm's unaudited income information in Feb 2020

Announcement of TTY Biopharm's unaudited income information in Feb 2020

2020.3.12

...

More

Announcement of TTY Biopharm's unaudited income information in Jan 2020

Announcement of TTY Biopharm's unaudited income information in Jan 2020

2020.2.10

...

More

TS-1® Capsule received TW NHI approval for Treatment of Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer

TS-1® Capsule received TW NHI approval for Treatment of Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer

2020.1.31 最新消息

...

More

LONSURF® get NHI reimbursement for metastatic colorectal cancer treatment since Dec/01/2018.

LONSURF® get NHI reimbursement for metastatic colorectal cancer treatment since Dec/01/2018.

2018.11.16 最新消息

...

More

TOP